BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5638159)

  • 1. [Revival of heparin therapy (role of calcium heparinate administered intracutaneously].
    Larcan A; Raby C; Streiff F; Calamai M; Alexandre P
    Presse Med (1893); 1968 Jan; 76(2):67-70. PubMed ID: 5638159
    [No Abstract]   [Full Text] [Related]  

  • 2. [The biologic control of long-term heparin therapy in the light of 115 cases of patients treated with subcutaneous calcium heparinate].
    Migne J; Monteil R
    Angeiologie; 1967; 19(5):27-31. PubMed ID: 5621969
    [No Abstract]   [Full Text] [Related]  

  • 3. [Remarks on the use of Ca heparinate by subcutaneous route in anticoagulant therapy].
    Vivien P
    Phlebologie; 1973; 26(1):15-21. PubMed ID: 4724445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of calcium heparinate in anticoagulant therapy].
    Vivien P; Allannic H; Loussouarn J; Turpin J
    Therapie; 1971; 26(1):141-8. PubMed ID: 5554761
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subcutaneous calcium heparinate: a new heparin].
    Desrochers Y
    Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sever complications due to subcutaneous calcium heparinate observed in neurosurgery].
    Corcos A; Le Beau J
    Sem Hop; 1971 Dec; 47(49):2807-10. PubMed ID: 4335743
    [No Abstract]   [Full Text] [Related]  

  • 7. [Control of subcutaneous calcium-heparin therapy by the thrombodensitogram].
    Porta A; Magni S; Camagna P; Donati M; Dinelli CA
    Minerva Med; 1985 Mar; 76(11):531-2. PubMed ID: 3982692
    [No Abstract]   [Full Text] [Related]  

  • 8. [Practical management of transcutaneous heparin therapy with concentrated calcium heparinate in the treatment and prevention of postoperativve thromboembolic disease].
    Favre J; Schvingt E; Hollender LF
    Lyon Chir; 1971; 67(2):147-50. PubMed ID: 5557694
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value and practical management of anticoagulant therapy by subcutaneous injection of concentrated calcium heparinate].
    Di Matteo J; Picard R; Cornu P; Vacheron A; Bousquet O
    Arch Mal Coeur Vaiss; 1968 May; 61(5):724-34. PubMed ID: 4971372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on subcutaneous Heparin administration].
    Popov-Cenić S; Borgolte H
    Med Welt; 1973 Nov; 24(44):1701-5. PubMed ID: 4764859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subcutaneous heparinotherapy. Clinical study of calcium heparinate].
    Warembourg H; Bertrand M
    Lille Med; 1968 Dec; 13(10):Suppl 7:1057+. PubMed ID: 5720291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant treatment with heparin].
    Langer B; Wolosker M; Albers MT
    Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic heparinization by subcutaneous route with individualized adjustment of the injected dose and of the time schedule of administration].
    Langer B; Montagnini AL; Kutner JM; Khoury V; Albers MT; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):35-9. PubMed ID: 6484439
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for administering heparin.
    Thurber CF
    J Maine Med Assoc; 1974 Sep; 65(9):212-3. PubMed ID: 4413614
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a subcutaneously administered heparin preparation].
    Stosiek U; Grumbrecht C
    Med Welt; 1974 Apr; 25(17):765-8. PubMed ID: 4417187
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolonged anticoagulant treatment by subcutaneous injections of calcium heparinate].
    Demange J; Renais J; Scebat L; Lenegre J
    Presse Med (1893); 1967 Jun; 75(29):1499-502. PubMed ID: 6026886
    [No Abstract]   [Full Text] [Related]  

  • 17. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
    Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.